Oppenheimer lowered the firm’s price target on Transcat (TRNS) to $130 from $155 and keeps an Outperform rating on the shares. The firm notes Transcat Q2 results fell short of expectations. Management cited weakness in NEXA and reduced its organic service revenue growth outlook to mid-single-digits growth until first half of 2026. Oppenheimer remains confident in its long-term thesis of sustained revenue growth and margin expansion.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TRNS:
- Transcat price target lowered to $126 from $156 at H.C. Wainwright
- Transcat, Inc. Reports Steady Q2 Revenue and Profit Growth
- Transcat reports Q2 adjusted EPS 52c, consensus 46c
- Transcat expects FY25 organic service revenue growth in mid-single digits
- TRNS Upcoming Earnings Report: What to Expect?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
